Pres2+S hepatitis B vaccine derived from plasma

Details Pres2+S hepatitis B vaccine derived from plasma Pres2+S hepatitis B vaccine derived from plasma

1988-09-01

1991-07-09

Draper, Garnette D.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Separation or purification

530412, 530415, 530418, 530422, 530402, 530403, 530405, 530406, 530427, 530827, 530830, 530380, 424 89, C07K 328, C07K 318

Patent

active

050307207

ABSTRACT:
Hepatitis B PreS2+S antigen is isolated from plasma by adsorption on an affinity chromatography column, elution with a chaotropic agent and treatment with concentrated urea at an elevated temperature. The process retains all or substantially all of the preS2+S antigen.

REFERENCES:
patent: 3636191 (1972-01-01), Blumberg et al.
patent: 4017360 (1977-04-01), Bertlandd et al.
patent: 4649192 (1987-03-01), Wignendarle et al.
patent: 4683293 (1987-07-01), Craig
patent: 4695454 (1987-09-01), Prince et al.
patent: 4707542 (1987-11-01), Fredman
patent: 4855055 (1989-08-01), Lin et al.
patent: 4897465 (1990-01-01), Cerdle et al.
Meyhack et al., Chem. Abst. vol. 103, 1983, #136419w.
Wampler et al., Modern Approaches to Vaccines, ed. Chanack et al., 1984, pp. 251-256.
Damodaran et al., Biochem. Biophys. Acta 801, 1984, pp. 416-423.
Stibbe et al., J. Virol. 46 (2):626-628 (1983).
Ohnuma et al., Clin. exp. Immunol. 67:709-715 (1986).

Affiliated with

Also associated with

Rating

Pres2+S hepatitis B vaccine derived from plasma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pres2+S hepatitis B vaccine derived from plasma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pres2+S hepatitis B vaccine derived from plasma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-619035